DXCM
Price
$74.49
Change
-$0.85 (-1.13%)
Updated
Sep 2, 04:24 PM (EDT)
Capitalization
29.54B
51 days until earnings call
RMD
Price
$270.99
Change
-$3.53 (-1.29%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
40.19B
51 days until earnings call
Interact to see
Advertisement

DXCM vs RMD

Header iconDXCM vs RMD Comparison
Open Charts DXCM vs RMDBanner chart's image
DexCom
Price$74.49
Change-$0.85 (-1.13%)
Volume$4.46K
Capitalization29.54B
ResMed
Price$270.99
Change-$3.53 (-1.29%)
Volume$4.9K
Capitalization40.19B
DXCM vs RMD Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. RMD commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and RMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (DXCM: $75.34 vs. RMD: $274.51)
Brand notoriety: DXCM and RMD are both not notable
DXCM represents the Medical/Nursing Services, while RMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DXCM: 89% vs. RMD: 131%
Market capitalization -- DXCM: $29.54B vs. RMD: $40.19B
DXCM [@Medical/Nursing Services] is valued at $29.54B. RMD’s [@Pharmaceuticals: Other] market capitalization is $40.19B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.61B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 1 FA rating(s) are green whileRMD’s FA Score has 0 green FA rating(s).

  • DXCM’s FA Score: 1 green, 4 red.
  • RMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RMD is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 4 TA indicator(s) are bullish while RMD’s TA Score has 4 bullish TA indicator(s).

  • DXCM’s TA Score: 4 bullish, 5 bearish.
  • RMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RMD is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical/Nursing Services) experienced а -8.41% price change this week, while RMD (@Pharmaceuticals: Other) price change was -6.54% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.48%. For the same industry, the average monthly price growth was +3.02%, and the average quarterly price growth was +13.14%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.05%. For the same industry, the average monthly price growth was +8.20%, and the average quarterly price growth was +29.89%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 23, 2025.

RMD is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.48% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.05% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($40.2B) has a higher market cap than DXCM($29.5B). DXCM has higher P/E ratio than RMD: DXCM (53.06) vs RMD (28.87). RMD YTD gains are higher at: 20.818 vs. DXCM (-3.125). RMD has higher annual earnings (EBITDA): 1.92B vs. DXCM (1.04B). DXCM has more cash in the bank: 2.93B vs. RMD (1.21B). RMD has less debt than DXCM: RMD (852M) vs DXCM (2.58B). RMD has higher revenues than DXCM: RMD (5.15B) vs DXCM (4.3B).
DXCMRMDDXCM / RMD
Capitalization29.5B40.2B73%
EBITDA1.04B1.92B54%
Gain YTD-3.12520.818-15%
P/E Ratio53.0628.87184%
Revenue4.3B5.15B84%
Total Cash2.93B1.21B242%
Total Debt2.58B852M303%
FUNDAMENTALS RATINGS
DXCM vs RMD: Fundamental Ratings
DXCM
RMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
4137
PRICE GROWTH RATING
1..100
6449
P/E GROWTH RATING
1..100
2675
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (38) in the Medical Specialties industry is somewhat better than the same rating for DXCM (81). This means that RMD’s stock grew somewhat faster than DXCM’s over the last 12 months.

RMD's Profit vs Risk Rating (64) in the Medical Specialties industry is somewhat better than the same rating for DXCM (100). This means that RMD’s stock grew somewhat faster than DXCM’s over the last 12 months.

RMD's SMR Rating (37) in the Medical Specialties industry is in the same range as DXCM (41). This means that RMD’s stock grew similarly to DXCM’s over the last 12 months.

RMD's Price Growth Rating (49) in the Medical Specialties industry is in the same range as DXCM (64). This means that RMD’s stock grew similarly to DXCM’s over the last 12 months.

DXCM's P/E Growth Rating (26) in the Medical Specialties industry is somewhat better than the same rating for RMD (75). This means that DXCM’s stock grew somewhat faster than RMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMRMD
RSI
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 5 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
71%
Momentum
ODDS (%)
Bearish Trend 5 days ago
62%
Bearish Trend 5 days ago
56%
MACD
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 5 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
52%
Advances
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 16 days ago
63%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
75%
Aroon
ODDS (%)
Bearish Trend 5 days ago
68%
Bullish Trend 5 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MUJ11.060.03
+0.27%
Blackrock Muniholdings NEW Jersey Quality Fund
PSCX29.690.05
+0.17%
Pacer Swan SOS Conservative (Jan) ETF
CPNQ25.86-0.01
-0.05%
Calamos Nasdaq-100 Str Alt Prt ETF-Dec
NOCT55.91-0.17
-0.30%
Innovator Growth-100 Pwr Buff ETF™ Oct
AVUS106.13-0.52
-0.49%
Avantis US Equity ETF

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with GKOS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then GKOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+0.35%
GKOS - DXCM
46%
Loosely correlated
-0.77%
VAPO - DXCM
43%
Loosely correlated
N/A
BSX - DXCM
41%
Loosely correlated
-0.24%
PODD - DXCM
41%
Loosely correlated
+0.68%
RMD - DXCM
35%
Loosely correlated
-0.32%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-0.32%
SOLV - RMD
46%
Loosely correlated
+0.59%
RVTY - RMD
42%
Loosely correlated
+0.99%
IDXX - RMD
41%
Loosely correlated
+0.01%
SYK - RMD
39%
Loosely correlated
+0.45%
NVST - RMD
37%
Loosely correlated
-0.33%
More